Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunology
Researchers from Forsyth Institute, Department of Immunology discuss findings in immunology
May 20th, 2009
New investigation results, 'Expression of receptor activator of nuclear factor-kappaB ligand by B cells in response to oral bacteria,' are detailed in a study published in Oral Microbiology and Immunology. "We investigated receptor activator of nuclear factor-kappaB ligand (RANKL) expression by B lymphocytes during early and late aspects of the immune response to Aggregatibacter actinomycetemcomitans, a gram-negative, anaerobic bacterium associated with aggressive periodontal disease. Expression of messenger RNA transcripts (tumor necrosis factor-alpha, Toll-like receptors 4 and 9, interleukins 4 and 10, and RANKL) involved in early (1-day) and late (10-day) responses in cultured...
Source: Vaccine Weekly (2009-05-20)
|
